Patent Law

U.S. Patent Office Invalidates Seagen Patent in Dispute between Daiichi Sankyo and Seagen

Retrieved on: 
Wednesday, January 17, 2024
Biotechnology, Health, Patent Law, Professional Services, Pharmaceutical, Daiichi Sankyo, District court, PGR, General counsel, Title, Patent, Pharmaceutical industry

Daiichi Sankyo Co., Ltd. (TSE: 4568) (hereinafter, Daiichi Sankyo) announced today that the U.S. Patent and Trademark Office (U.S. PTO) rendered a Final Written Decision invalidating all claims of Seagen Inc.’s U.S. patent 10,808,039 (the ’039 patent) that were challenged by Daiichi Sankyo in a post-grant review proceeding (PGR).

Key Points: 
  • Daiichi Sankyo Co., Ltd. (TSE: 4568) (hereinafter, Daiichi Sankyo) announced today that the U.S. Patent and Trademark Office (U.S. PTO) rendered a Final Written Decision invalidating all claims of Seagen Inc.’s U.S. patent 10,808,039 (the ’039 patent) that were challenged by Daiichi Sankyo in a post-grant review proceeding (PGR).
  • “We are pleased that the U.S. PTO invalidated all challenged claims of the ’039 patent,” said Naoto Tsukaguchi, Corporate Officer and General Counsel, Daiichi Sankyo.
  • On December 23, 2020, Daiichi Sankyo filed a PGR petition with the U.S. PTO contesting the patentability of certain claims of the ’039 patent.
  • On April 7, 2022, the U.S. PTO granted Daiichi Sankyo’s request to institute the PGR.

Aggregator Arranged Video Patent Deal Brings Licensing Efficiency

Retrieved on: 
Friday, January 12, 2024
Professional Services, Patent Law, Apps, Applications, Technology, Audio, Video, Telecommunications, Software, KAIST, NTT Docomo, KBS, Korean Broadcasting System, Toshiba, SK Planet, JVCKenwood, ETRI, SK Telecom, RPX, Patent, General Electric, NTT

RPX and Sisvel, both aggregators, represented a group of 16 technology companies and 20 patent owners, respectively, to conclude a transaction related to video codecs.

Key Points: 
  • RPX and Sisvel, both aggregators, represented a group of 16 technology companies and 20 patent owners, respectively, to conclude a transaction related to video codecs.
  • The agreement provides participants with a license to patents in Sisvel’s Video Coding Licensing Platform, and resulted in significant transactional efficiencies.
  • All are represented by Sisvel and participate in the firm’s Video Coding Licensing Platform.
  • Sisvel is driven by a belief in the importance of collaboration, ingenuity and efficiency to bridge the needs of patent owners and those who wish to access their technologies.

Moses Singer Appoints Melissa Bassin and John Baranello to Partner

Retrieved on: 
Wednesday, January 10, 2024
Professional Services, Patent Law, Legal, Commercial Building & Real Estate, Finance, Construction & Property, Accounting, JD, Baranello, Advertising, Partnership, Rutgers Law School, George Washington University, University, Fraud, Environment, Acquisition, Intellectual property, Health, Property management

Moses & Singer LLP is pleased to announce the election of Melissa Bassin and John Baranello to partner, effective January 1, 2024.

Key Points: 
  • Moses & Singer LLP is pleased to announce the election of Melissa Bassin and John Baranello to partner, effective January 1, 2024.
  • John was a summer associate at Moses Singer and has spent his entire career at the firm.
  • “We are delighted to welcome Melissa and John to the partnership,” said Dean Swagert, Moses Singer’s Managing Partner.
  • Since 1919, Moses Singer has represented diverse businesses and successful individuals and their families.

Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values

Retrieved on: 
Tuesday, January 2, 2024
Technology, Health Technology, General Sports, Other Science, Artificial Intelligence, Research, Medical Devices, Professional Services, Health, Wearables, Mobile Technology, General Health, Nanotechnology, Science, Other Technology, Software, Hardware, Electronic Design Automation, Sports, Data Management, Patent Law, Consumer Electronics, Other Health, Biometrics, Prior art, ECG, Multimedia, Athlete, Collection, Heart rate, Biomarker, Patent, Sensor, AI, Sport, Insurance, Intelligence, United States patent law, Pharmaceutical industry

11,850,053 to the company covering a novel system and method for calculating accurate, real-time heart rate (HR) measurements from high sampling, electrocardiogram (ECG)-based sensors.

Key Points: 
  • 11,850,053 to the company covering a novel system and method for calculating accurate, real-time heart rate (HR) measurements from high sampling, electrocardiogram (ECG)-based sensors.
  • SD Labs’ issued patent, entitled “A System and Method for Measuring Heart Rate,” also covers a novel method for detecting and replacing missing and outlier sensor-based data values with artificial (i.e., synthetic) data.
  • The issued patent also covers an AI-based method for generating predictive artificial data values for any missing or outlier values within a sensor-based data set, which can be applicable to all types of biological sensor data regardless of sensor type.
  • “Our synthetic data generator enables more complete data sets to be created, a requisite for AI systems to be more effective in analyzing and creating value with data.

Japanese Patent Holder BWB Files Milestone Intellectual Property Infringement Complaint Against Retail Giant Alibaba Group

Retrieved on: 
Friday, December 22, 2023
Legal, Finance, Patent Law, Professional Services, Online Retail, Logistics, Supply Chain Management, Transport, Retail, Tokyo District Court, BWB, Patent, IP, Alibaba Group, Goliath, District court

In a legal challenge that could have multi-billion-dollar consequences, Tokyo-based BWB Inc. is pursuing a patent infringement lawsuit against global e-commerce technology giant Alibaba Group .

Key Points: 
  • In a legal challenge that could have multi-billion-dollar consequences, Tokyo-based BWB Inc. is pursuing a patent infringement lawsuit against global e-commerce technology giant Alibaba Group .
  • The David vs. Goliath lawsuit, should it be decided in BWB’s favor, could set a legal precedent in e-commerce technology as the operational foundation of Alibaba and other dominant retail sites.
  • These technology patents were issued to BWB CEO and inventor Ryutaro Nishiura between 2019-2023.
  • Previously, BWB filed suit in Japan for alleged infringement of IP rights, and a trial is currently underway in the Tokyo District Court, pitting BWB against defendants Alibaba Japan, Taobao China Holding Co. Ltd. and Hangzhou Cainiao Smart Logistics Network Ltd.

AHF: WHO's Tedros Sides with Big Pharma on Patents

Retrieved on: 
Thursday, December 21, 2023
Medical Supplies, AIDS, Professional Services, Health, Philanthropy, General Health, Patent Law, Pharmaceutical, Infectious Diseases, Foundation, COVID-19, Coronavirus, WHO, Vaccine, AHF, Therapy, AIDS Healthcare Foundation, Pandemic, IP, World Health Organization, Pharmaceutical industry

“Dr.

Key Points: 
  • “Dr.
  • Tedros’ remarks are not only dangerous and tone deaf – they are an inexplicable reversal from the support he’s shown for IP waivers in the past.
  • Dr. Tedros and the WHO must be on the side of human life – not big pharma and the ultra-rich.”
    In June 2022, the WTO approved an IP waiver for COVID-19 vaccine patents.
  • Since then, advocates and many nations have urged the WTO to extend the waiver to include tests and treatments for the novel coronavirus.

Chemours Works with Authorities in Northern China to Shutdown Chemical Plant Producing Fake Viton™ FreeFlow

Retrieved on: 
Monday, December 18, 2023
Professional Services, Law Enforcement, Emergency Services, Patent Law, Public Policy, Government, Chemicals, Plastics, Manufacturing, Business, Law enforcement, Safety, Drug

Law enforcement agencies in northern China have shut down large-scale manufacturing of counterfeit Viton™ FreeFlow™ fluoroelastomer, a product falsely bearing Chemours' trademarks, at a local chemical plant.

Key Points: 
  • Law enforcement agencies in northern China have shut down large-scale manufacturing of counterfeit Viton™ FreeFlow™ fluoroelastomer, a product falsely bearing Chemours' trademarks, at a local chemical plant.
  • The value of the counterfeit products was reported to be in the millions of dollars.
  • The plant and its affiliated entities reportedly purchased genuine Viton™ FreeFlow™ fluoroelastomer from Chemours local subsidiaries to help mask their counterfeiting operations.
  • “This operation represents a significant stride in our ongoing battle against counterfeit production and the illicit trade of fake goods,” said Eric von Brockdorff, Global Product & Business Director for Chemours.

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program

Retrieved on: 
Wednesday, December 6, 2023
Alternative Medicine, Professional Services, Patent Law, Mental Health, Health, Pharmaceutical, Biotechnology, Patent, NEO, Safety, NYSE, Depression, Patient, Inc., MDD, Pharmaceutical industry

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,834,410 in support of its CYB003 program.

Key Points: 
  • Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,834,410 in support of its CYB003 program.
  • The patent, which is expected to provide exclusivity until at least 2041, includes composition of matter claims to pharmaceutical compositions within the Company’s proprietary deuterated psilocybin analog program, CYB003, as well as claims directed toward the therapeutic treatment of major depressive disorder (“MDD”), treatment-resistant depression, and alcohol use disorder.
  • “Securing robust patent protection for our proprietary products is a top priority, and we are pleased to announce this additional U.S. patent supporting our CYB003 program,” said Doug Drysdale, Chief Executive Officer of Cybin.
  • “Last week, we shared positive Phase 2 topline safety and efficacy data for CYB003 in MDD.

edatanetworks Inc. Receives Patents from the USPTO, Advancing Digital Commerce for Communities

Retrieved on: 
Tuesday, December 5, 2023
Data Management, Online Retail, Technology, Professional Services, Payments, Philanthropy, Patent Law, Electronic Commerce, Other Philanthropy, Retail, Internet, Marketing, Patent, DNA, Human, IP, Ecosystem

Consumers can also use their voice to request offers from the near-by businesses.

Key Points: 
  • Consumers can also use their voice to request offers from the near-by businesses.
  • These businesses commit to supporting the local community non-profit organizations each time a participating consumer makes a purchase.
  • The platform detailed in this patent brings together merchants, consumers, and non-profits in the local community through digital commerce and the utilization of rich tokenized transaction data.
  • These merchants also benefit from the good-will generated through their micro-donations to the communities where they live and prosper.”

Wilson Sonsini Goodrich & Rosati Elects 20 New Partners

Retrieved on: 
Monday, December 4, 2023
Legal, Professional Services, Business, Patent Law

Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that the firm has elected 20 new partners from its attorney ranks.

Key Points: 
  • Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that the firm has elected 20 new partners from its attorney ranks.
  • “While each class is unique in many ways, we believe each group reflects the strengths and diversity of our talent pipeline,” said Doug Clark, Wilson Sonsini’s managing partner.
  • Based in San Diego, Castillo serves as outside general counsel to life sciences and technology companies at all stages of development.
  • Castillo also advises venture capital funds on structuring and executing investment transactions and managing their existing portfolio companies.